Announcements Trials

Browse Landscape

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Melanoma 1

Interventions

Cyclophosphamide 3155 Cisplatin 3151 Carboplatin 2929 Paclitaxel 2671 Radiotherapy 2643 Gemcitabine 2544 pembrolizumab 2324 Docetaxel 2154 Bevacizumab 2126 Fluorouracil 1819 Capecitabine 1780 Oxaliplatin 1709 Dexamethasone 1589 Nivolumab 1516 Doxorubicin 1477 Rituximab 1453 Etoposide 1341 Magnetic Resonance Spectroscopy 1261 Irinotecan 1232 Leucovorin 1212 Cytarabine 1123 Pemetrexed 1060 Drug Therapy 1060 fludarabine 1044 Vincristine 956 Specimen Handling 928 Prednisone 924 Cetuximab 919 Lenalidomide 916 Trastuzumab 897

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Ruthenium-106 × Clear all

NCT05893654 2025-09-15

MELCOM

Hospital das Clínicas de Ribeirão Preto

Phase 1/2 Enrolling by invitation

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡